1. Home
  2. ICUI vs PLSE Comparison

ICUI vs PLSE Comparison

Compare ICUI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

N/A

Current Price

$159.20

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$49.44

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUI
PLSE
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.6B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
ICUI
PLSE
Price
$159.20
$49.44
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
★ $193.38
$54.00
AVG Volume (30 Days)
209.0K
★ 565.6K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.62
N/A
EPS
★ 1.96
N/A
Revenue
★ $2,231,262,000.00
N/A
Revenue This Year
N/A
$477.71
Revenue Next Year
$4.44
$233.00
P/E Ratio
$82.31
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$112.50
$12.56
52 Week High
$192.85
$58.90

Technical Indicators

Market Signals
Indicator
ICUI
PLSE
Relative Strength Index (RSI) 42.35 48.04
Support Level $152.02 $49.01
Resistance Level $160.22 $57.82
Average True Range (ATR) 4.47 3.22
MACD 0.32 -0.78
Stochastic Oscillator 41.28 22.44

Price Performance

Historical Comparison
ICUI
PLSE

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Share on Social Networks: